Aptinyx (APTX) Reports In-Line Q1 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to Aptinyx (APTX) Reports In-Line Q1 EPS

Aptinyx Reports First Quarter 2021 Financial Results and Highlights

May 13, 2021 4:05 PM EDT

Enrollment on track in both Phase 2b studies of NYX-2925 in chronic paindata readouts expected 1H 2022

Preparing for NYX-783 Phase 2b PTSD study following recent FDA meetingstudy initiation expected in 2H 2021

Recommenced Phase 2 study of NYX-458 in patients with cognitive impairmentdata readout expected 2H 2022

$146.8 million cash position expected to support operations through multiple Phase 2 readouts and into 2023

Conference call today at 5:00 p.m. ET

EVANSTON, Ill.--(BUSINESS WIRE)-- Aptinyx Inc. (Nasdaq:... More